6. Parkinson disease Clinical trials / Disease details
Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04957095 (ClinicalTrials.gov) | February 18, 2022 | 29/6/2021 | Motor Network Physiology | Motor Network Physiology Characterization During Deep Brain Stimulation Surgery | Parkinson Disease;Essential Tremor | Drug: Inbrija;Other: Subcortical Stimulation | University of Texas Southwestern Medical Center | University of California, Los Angeles;National Institute of Neurological Disorders and Stroke (NINDS) | Recruiting | 18 Years | 89 Years | All | 120 | United States |